A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants
Clinical trial NCT05932277 · COMPLETED
Trial details
- NCT number
- NCT05932277
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2023-09-13
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.